Vitamin D and lumisterol emerge as cheap and easily accessible potential treatments for COVID-19

Promising new data from a recent study indicates that active forms of vitamin D can inhibit the replication and expansion of COVID-19. The study’s findings also suggest lumisterol, produced by a chemical reaction in the body using light, works to block COVID-19. Vitamin D and lumisterol metabolites were able to block two specific enzymes (RdRP and Mrpo) required for the SARS-CoV-2 life cycle, according to the team of researchers from the University of Alabama at Birmingham; the Centre for Interdisciplinary Research in Basic Sciences in New Delhi, India; and the University of Western Australia. The study is published in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for September.

This post was originally published on this site